157 related articles for article (PubMed ID: 6352019)
1. Decreased natural killer cell activity in children with untreated acute leukemia.
Nasrallah AG; Miale TD
Cancer Res; 1983 Nov; 43(11):5580-5. PubMed ID: 6352019
[TBL] [Abstract][Full Text] [Related]
2. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
Pattengale PK; Sundstrom C; Yu AL; Levine A
Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
[TBL] [Abstract][Full Text] [Related]
3. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission.
Inada M; Okawa H; Suzuki M; Yata J
Jpn J Clin Oncol; 1984 Sep; 14(3):335-45. PubMed ID: 6592376
[TBL] [Abstract][Full Text] [Related]
4. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
Torelli GF; Guarini A; Maggio R; Alfieri C; Vitale A; Foà R
Haematologica; 2005 Jun; 90(6):785-92. PubMed ID: 15951291
[TBL] [Abstract][Full Text] [Related]
5. Natural killer activity in patients with acute myelocytic leukemia.
Stupp Y; Rosenkovitch E; Izak G
Isr J Med Sci; 1978 Dec; 14(12):1212-5. PubMed ID: 311767
[TBL] [Abstract][Full Text] [Related]
6. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
Sharma B; Vaziri ND
Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
[TBL] [Abstract][Full Text] [Related]
8. Analysis of natural killer cell defects in childhood acute lymphoblastic leukemia.
Yamada S; Miyagawa Y; Komiyama A; Akabane T
Jpn J Clin Oncol; 1984 Mar; 14(1):75-80. PubMed ID: 6608609
[TBL] [Abstract][Full Text] [Related]
9. Defect of NK activity in children with untreated acute lymphocytic leukemia (ALL). I. Dependence on the blast count and phenotype, and response to exogenous and endogenous alpha-interferon.
Gabrilovac J; Rajić L; Martin-Kleiner I; Osmak M; Batinić D; Tiefenbach A; Boranić M
J Clin Lab Immunol; 1989 May; 29(1):9-15. PubMed ID: 2628585
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
Uchida A; Yanagawa E
J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of purified Leu 19+ cells from the peripheral blood of children with acute lymphocytic leukemia.
Afify ZA; Abdel-Mageed A; Findley HW; Ragab AH
Cancer; 1990 Aug; 66(3):469-73. PubMed ID: 1694716
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell and islet killer cell activities in human type 1 diabetes.
Negishi K; Waldeck N; Chandy G; Buckingham B; Kershnar A; Fisher L; Gupta S; Charles AM
Exp Clin Endocrinol; 1987 Aug; 89(3):345-53. PubMed ID: 3311777
[TBL] [Abstract][Full Text] [Related]
13. [Cytotoxic action of natural killer cells on human tumor cells].
Avdeev GI; Viadro MM; Leĭkin IuD; Timofeevskaia EA; Osipov SG
Biull Eksp Biol Med; 1985 Apr; 99(4):471-3. PubMed ID: 3986372
[TBL] [Abstract][Full Text] [Related]
14. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
15. [Spontaneous lymphocyte-mediated cytotoxicity and antibody-dependent cell cytotoxicity of human effector cells].
Thränhardt H; Soeberdt R; König A; Zintl F; Metz O; Plenert W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(6):831-42. PubMed ID: 6200394
[TBL] [Abstract][Full Text] [Related]
16. [Human nonspecific killer cells].
Thränhardt H; Zintl F; Milleck J; Jantscheff P; Hermann J; Fuchs D; Voigt P; Metz O; Löbe LP; Mohr F; Plenert W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):390-407. PubMed ID: 6182059
[TBL] [Abstract][Full Text] [Related]
17. Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors.
Moy PM; Holmes EC; Golub SH
Cancer Res; 1985 Jan; 45(1):57-60. PubMed ID: 3855286
[TBL] [Abstract][Full Text] [Related]
18. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
Klingemann HG; Wong E; Maki G
Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
[TBL] [Abstract][Full Text] [Related]
19. Natural killer (NK) activity in children with acute lymphoblastic leukemia.
Tanaka Y
Hiroshima J Med Sci; 1981 Jun; 30(2):127-33. PubMed ID: 6946050
[No Abstract] [Full Text] [Related]
20. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
